Genprex (2DE1) Stock Statistics & Valuation Metrics
Total Valuation
Genprex has a market cap or net worth of EUR 1.64M. The enterprise value is -EUR 17.26T.
- Market Cap
- EUR 1.64M
- Enterprise Value
- -EUR 17.26T
Share Statistics
Genprex has 819,709 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 819,709
- Owned by Insiders
- 10.43%
- Owned by Institutions
- 2.07%
Financial Efficiency
Genprex’s return on equity (ROE) is -2.04 and return on invested capital (ROIC) is -194.32%.
- Return on Equity (ROE)
- -2.04
- Return on Assets (ROA)
- -1.60
- Return on Invested Capital (ROIC)
- -194.32%
- Return on Capital Employed (ROCE)
- -1.94
- Revenue Per Employee
- 0
- Profits Per Employee
- -1.25M
- Employee Count
- 13
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Genprex is -0.01. Genprex’s PEG ratio is -0.00.
- PE Ratio
- -0.01
- PS Ratio
- 0.00
- PB Ratio
- 0.07
- Price to FCF
- -0.07
- Price to Operating Cash Flow
- -0.07
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Genprex had revenue of 0 and earned -16.23M in profits. Earnings per share was -382.80.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -15.52M
- Pretax Income
- -16.23M
- Net Income
- -16.23M
- EBITDA
- -15.49M
- Earnings Per Share (EPS)
- -382.80
Cash Flow
In the last 12 months, operating cash flow was -15.56M and capital expenditures 5, giving a free cash flow of -15.56M billion.
- Operating Cash Flow
- -15.56M
- Free Cash Flow
- -15.56M
- Free Cash Flow per Share
- -32.89
Dividends & Yields
Genprex pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1375.95%
- Earnings Yield
- -1556.64%
Stock Price Statistics
- Beta
- -0.30
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 3.96
- 200-Day Moving Average
- 3.96
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Genprex as a current ratio of 3.84, with Debt / Equity ratio of 0.00%
- Current Ratio
- 3.84
- Quick Ratio
- 3.84
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.51
- Interest Coverage Ratio
- -20.97
Taxes
In the past 12 months, Genprex has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Genprex EV to EBITDA ratio is 0.89, with an EV/FCF ratio of 0.90.
- EV to Sales
- 0.00
- EV to EBITDA
- 0.89
- EV to Free Cash Flow
- 0.90
- EV to Operating Cash Flow
- 0.90
Balance Sheet
Genprex has EUR 15.15M in cash and marketable securities with EUR 0.00 in debt, giving a net cash position of EUR 15.15M billion.
- Cash & Marketable Securities
- EUR 15.15M
- Total Debt
- EUR 0.00
- Net Cash
- EUR 15.15M
- Net Cash Per Share
- EUR 18.49
- Tangible Book Value Per Share
- EUR 31.27
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Genprex is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 93.55%
